CONFLICT OF INTEREST STATEMENT
ONCOLOGY
Laurent Zelek reports personal consulting fees as an advisory board member for Vifor during the conduct of the study and personal fees from Novartis, Roche, Lilly, Sandoz and Pfizer, outside the submitted work. Rudolph Navari has nothing to disclose. Matti Aapro reports serving in a consulting/advisory role for Amgen, BMS, Daiichi Sankyo, Fresenius Kabi, G1 Therapeutics, Genomic Health, Helsinn Healthcare, Merck, Merck KGaA, Novartis, Pfizer, Pierre Fabre, Roche, Sandoz, Tesaro, and Vifor Pharma; speakers' bureau at Accord Research, Amgen, Biocon, Dr Reed, Genomic Health, Helsinn Healthcare, Mundipharma, Novartis, Pfizer, Pierre Fabre, Roche, Sandoz, Taiho Pharmaceutical, Tesaro, and Vifor Pharma; and receiving research funding from Helsinn Healthcare, Novartis, Pierre Fabre, and Sandoz. Florian Scotté reports personal consulting fees as an advisory board member for Helsinn Healthcare, Vifor, MSD and Tesaro during the conduct of the study and personal fees from Roche, Amgen, Pfizer, Leo Pharma, Mylan, Mundi Pharma, Clovis Oncology, BMS, Biogaran, Pierre Fabre Oncology, Arrow and GSK outside the submitted work.